Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PT Pyridam Farma Tbk's share price for the quarter that ended in Mar. 2026 was Rp310. PT Pyridam Farma Tbk's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 11,237 Mil. Therefore, PT Pyridam Farma Tbk's market cap for the quarter that ended in Mar. 2026 was Rp3,483,375 Mil.
PT Pyridam Farma Tbk's quarterly market cap
declined
from Sep. 2025 (Rp6,573,465 Mil) to Dec. 2025 (Rp5,348,666 Mil) and
declined
from Dec. 2025 (Rp5,348,666 Mil) to Mar. 2026 (Rp3,483,375 Mil).
PT Pyridam Farma Tbk's annual market cap
increased
from Dec. 2023 (Rp612,667 Mil) to Dec. 2024 (Rp2,359,703 Mil) and
increased
from Dec. 2024 (Rp2,359,703 Mil) to Dec. 2025 (Rp5,348,666 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PT Pyridam Farma Tbk's Enterprise Value for Today is Rp7,497,539 Mil.
PT Pyridam Farma Tbk (ISX:PYFA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PT Pyridam Farma Tbk Market Cap Related Terms
PT Pyridam Farma Tbk Market Cap Historical Data
* Premium members only.
The historical data trend for PT Pyridam Farma Tbk's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:PYFA vs ZTS, UTHR, VTRS: Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PT Pyridam Farma Tbk's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Pyridam Farma Tbk Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Pyridam Farma Tbk's Market Cap distribution charts can be found below:
* The bar in red indicates where PT Pyridam Farma Tbk's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PT Pyridam Farma Tbk's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Pyridam Farma Tbk (ISX:PYFA) has a Market Cap of Rp2,269,823 Mil as of Jul. 06, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Pyridam Farma Tbk and its competitors. According to the industry distribution chart, PT Pyridam Farma Tbk ranks #582 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 56.8%.
Is PT Pyridam Farma Tbk's Market Cap too high?
PT Pyridam Farma Tbk's current Market Cap is Rp2,269,823 Mil. Based on the distribution chart, PT Pyridam Farma Tbk ranks #582 out of 1024 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, PT Pyridam Farma Tbk has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Pyridam Farma Tbk's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PT Pyridam Farma Tbk ranks #582 out of 1024 companies for Market Cap. This places PT Pyridam Farma Tbk in the lower half of its industry. The industry median Market Cap is 214.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 214.89, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Pyridam Farma Tbk and its competitors. For the Drug Manufacturers industry, the median Market Cap is 214.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Pyridam Farma Tbk's current Market Cap is Rp2,269,823 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Pyridam Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Pyridam Farma Tbk (ISX:PYFA) is currently considered Fairly Valued. The stock's GF Value™ is Rp212.60, compared to a current price of Rp202.00 — trading 5% below its estimated fair value. The current Market Cap is Rp2,269,823 Mil. PT Pyridam Farma Tbk's overall GF Score™ is 66/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PT Pyridam Farma Tbk (ISX:PYFA), the current Market Cap is Rp2,269,823 Mil as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Pyridam Farma Tbk (ISX:PYFA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Pyridam Farma Tbk stock appears to be undervalued.
The current stock price of Rp202.00 is trading 5% below its estimated GF Value™ of Rp212.60.
GuruFocus considers PT Pyridam Farma Tbk to be Fairly Valued.
Key valuation signals for ISX:PYFA:
Market Cap: Rp2,269,823 Mil
GF Value™: Rp212.60 vs. price of Rp202.00 (5% below fair value)
No single metric tells the full story. See the ISX:PYFA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Pyridam Farma Tbk is engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through two segments namely Pharmaceutical products, Esthetics, and Toll manufacturing services; and Medical equipment Products segment. The company derives maximum revenue from Pharmaceutical products, Esthetics, and Toll manufacturing services. The company's products include consumer health, Derma, prescription, and biomedilab.
66GF Score
Get the complete analysis for ISX:PYFA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PYFA has been successfully added to your 
